Tubular epithelia are a basic building block of organs and a common site of cancer occurrence [1] [2] [3] [4] . During tumorigenesis, transformed cells overproliferate and epithelial architecture is disrupted. However, the biophysical parameters that underlie the adoption of abnormal tumour tissue shapes are unknown. Here we show in the pancreas of mice that the morphology of epithelial tumours is determined by the interplay of cytoskeletal changes in transformed cells and the existing tubular geometry. To analyse the morphological changes in tissue architecture during the initiation of cancer, we developed a three-dimensional whole-organ imaging technique that enables tissue analysis at single-cell resolution. Oncogenic transformation of pancreatic ducts led to two types of neoplastic growth: exophytic lesions that expanded outwards from the duct and endophytic lesions that grew inwards to the ductal lumen. Myosin activity was higher apically than basally in wild-type cells, but upon transformation this gradient was lost in both lesion types. Threedimensional vertex model simulations and a continuum theory of epithelial mechanics, which incorporate the cytoskeletal changes observed in transformed cells, indicated that the diameter of the source epithelium instructs the morphology of growing tumours. Three-dimensional imaging revealed that-consistent with theory predictions-small pancreatic ducts produced exophytic growth, whereas large ducts deformed endophytically. Similar patterns of lesion growth were observed in tubular epithelia of the liver and lung; this finding identifies tension imbalance and tissue curvature as fundamental determinants of epithelial tumorigenesis.
. Here we address how changes in cellular forces contribute to tumour formation in the context of an intact epithelium, using the pancreatic duct as a model. To preserve the geometric complexity of the adult pancreas, we developed a technique for rapid, whole-organ 3D immunostaining and imaging, which we term 'fast light-microscopic analysis of antibody-stained whole organs' (FLASH; see Methods); this technique enables robust quantitative assessment of organ architecture at the single-cell and tissue level. FLASH maintained pancreatic compartmentalization and tissue integrity (Extended Data Fig. 1a, b) . We visualized the adult pancreatic ductal system by inducing expression of tdTomato in all duct cells (of Rosa26 CAG-tdTomato ;Hnf1b creERT2 mice). FLASH imaging of whole pancreata revealed an intricate hierarchy of tubules that span the exocrine lobules ( (Fig. 1c, d) , with smaller ducts composed of elongated cells and large ducts of cuboidal cells (Fig. 1e, f) . Confetti labelling showed clonal expansion predominantly along the cell elongation axis (Extended Data Fig. 1e , f). These findings illuminate the complexity and heterogeneity of the ductal system of the pancreas (Fig. 1g) .
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Hnf1b
CreERT2 mouse. n = 3 mice. a, Whole pancreas attached to duodenum and spleen. b, Enlargement of area outlined by the dashed rectangle in a. c, Ductal segments corresponding to numbered rectangles in b, showing main duct (1), interlobular duct (2), intralobular duct (3) and intercalated ducts (4) . d, Segmental heterogeneity of duct diameter. Mean ± s.d.; n = 11 main ducts, n = 67 interlobular ducts, n = 34 intralobular ducts and n = 72 intercalated ducts from 3 mice. e, Pancreas tissue section stained for Cdh1 and DNA to highlight shapes of duct cells. n = 4 mice. f, Segmental heterogeneity of duct cell width (black), height (red) and length (blue); averages of 5 cells per duct, n = 115 ducts from 6 mice. Fitted lines were obtained using nonlinear regression. g, Segmental heterogeneity of the ductal tree. L, cell length; W, cell width; H, cell height. Scale bars: 5 mm (a), 500 μm (b), 100 μm (c), 10 μm (e).
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To trigger epithelial deformations, we induced conditional mosaic activation of the Kras G12D oncogene with concomitant deletion of either p53 or Fbw7 tumour suppressors 1, 2, 6 . FLASH analysis of Kras creERT (hereafter, KFH) mice revealed two morphologically distinct lesion types, which co-occurred in all pancreata we analysed. Transformed ducts either evaginated basally away from the duct lumen (designated 'exophytic'), or invaginated apically towards the duct lumen (designated 'endophytic') ( , which progressed to back-to-back gland-like ductal neoplasia (Fig. 2d) .
By contrast, endophytic lesions grew into the duct lumen in a papillary manner (Fig. 2e , f, Extended Data Fig. 2e and Supplementary Video 3) and progressed to intratubular neoplasia with local obstruction of the duct lumen (Fig. 2g) . Activation of Kras G12D and deletion of Fbw7 or p53 in acinar cells (located at the tips of small-calibre ducts) induced acinar-to-ductal metaplasia, which led to Krt19-positive globular lesions that were continuous with the ductal tree (Extended Data Fig. 3a-h and Supplementary Videos 4, 5). In mice with duct-specific (referred to as KPCk19 mice) or pancreas-wide (referred to as KPC mice) Kras G12D activation and p53 deletion 1,2,7 , we also identified exophytic and endophytic lesions, which indicates that these observations are not dependent on a particular oncogene combination (Extended Data Fig. 4a-e) . Lesions with endophytic and Letter reSeArCH exophytic morphology were also observed in the pancreatic tissue of patients with pancreatic ductal adenocarcinoma (Extended Data  Fig. 4f) .
Pancreatic cancer cells co-opt pancreatic stellate cells as cancerassociated fibroblasts, which support tumour invasion and metastasis 8, 9 . Both mouse and human exophytic lesions-which invade the surrounding parenchyma-recruited cancer-associated fibroblasts more efficiently than the endophytic lesions that grow into the duct lumen, although both lesion types showed rapid proliferation (Extended Data Fig. 5a-c) . Advanced exophytic lesions displayed more prominent epithelial-to-mesenchymal transition, as judged by the number of tumour-traced mesenchymal cells (Extended Data Fig. 5d, e) . Thus, exophytic growth fosters more aggressive lesion development.
Because tissue morphology depends on cellular tension and contractility, which is driven by the actomyosin cortex 10 , we quantified the distribution of the key cortex components F-actin and pMLC2 (phosphorylated myosin light chain 2) [11] [12] [13] in single cells in KFCk19 and KPC mice, shortly after oncogene activation and before the occurrence of neoplastic lesions. The intensity of F-actin and pMLC2 staining was higher apically than basally in wild-type cells. Upon transformation, this gradient was strongly reduced (Fig. 2h-k and Extended Data Fig. 6a-h ). Acinar-derived lesions, which show redistributed F-actin 14, 15 , displayed a similar apical-basal shift of pMLC2 (Extended Data Fig. 6i, j) ; this supports the notion that the effect of transformation is independent of cell type. Phosphorylated focal adhesion kinase and vinculin were redistributed in the same manner as F-actin in these lesions, and the integrins Itga2, Itga6 and Itgb1 16 were overexpressed basally (Extended Data Fig. 6k, l) . When cultured in vitro as organoids, pancreatic cells from KPC mice displayed disruptions of the pMLC2 gradient that were similar to those observed in vivo (Fig. 2l, m) .
We then investigated possible molecular mechanisms that may underpin pMLC2 perturbation in transformed cells. Phosphatase inhibition in wild-type organoids abolished the apical-basal pMLC2 gradient, which suggests that phosphatase activity contributes to pMLC2 polarization (Extended Data Fig. 7a-d) . Disruption of apicalbasal polarization has previously been reported in Kras transformed cells, and oncogenic Kras signalling stimulates pMLC2 17, 18 . ERK, a target of MEK, regulates actin polymerization 19 and activates myosin light-chain kinase, which phosphorylates MLC2 20, 21 . We found that Kras
G12D
;Pdx1 cre (hereafter, KC) mice contained ductal structures that had an equal apical-basal pMLC2 distribution, which is consistent with the observed distribution of F-actin in KC mice 14 (Extended Data Fig. 7e, f) . Furthermore, apical pMLC2 accumulation could be partially restored by inhibition of MEK in KPC organoids. Overall, these results identify oncogenic hyperactivation of Kras-MEK-ERK as a driver of shifts in pMLC2, possibly by overriding phosphatase activity ( Fig. 2n and Extended Data Fig. 7g-j) . By contrast, ROCK inhibition led to an overall reduction of pMLC2, without affecting its relative distribution (Extended Data Fig. 7k-n) .
To test whether the pMLC2 perturbation in transformed cells could explain the observed lesion deformation, we developed a computational model of the pancreatic duct using a 3D vertex model simulation, which integrates duct cell geometry, apical, basal and lateral surface tensions, and cell volume conservation 22, 23 (Fig. 3a) . We assumed that apical and basal surface tensions in wild-type and transformed cells were proportional to the relative fluorescence intensities of pMLC2 11, 12, 24 ( Fig. 3b and Supplementary Modelling Procedures). To mimic oncogenic transformation, we introduced a single cell with surface tensions that were modified in accordance with changes in experimentally measured average pMLC2 fluorescence intensity (Fig. 2j) , and simulated successive rounds of cell division (Fig. 3b) to match cell counts that were experimentally observed at different time points. Simulations were performed for tubes of different diameters by varying the number of circumferential cells (Extended Data Fig. 8a) . Notably, without further fitting, we found evaginating and invaginating deformations that closely resembled those observed in the pancreas (Fig. 3c) . Furthermore, simulations showed a transition from evaginating deformations in small ducts to invaginating deformations in large ducts at about 17 μm diameter ( Fig. 3d and Extended Data Fig. 8b) . In simulations in which only cellular proliferation was considered (that is, without changes in the surface tension of the transformed cells), deformations were exophytic and no transition was observed (Extended Data Fig. 8c ).
To assess whether lesion shape correlated with ductal diameter in vivo, we measured the radial deformation of transformed pancreatic ducts of KFCk19 mice throughout the ductal tree. Notably, transformed ducts with a diameter of less than 17 μm deformed exophytically, whereas ducts with a diameter of greater than 17 μm deformed endophytically, consistent with the model predictions ( Fig. 3d and Extended Data Fig. 8d ). These observations, together with our computational model, strongly suggested that ductal deformations are dependent on duct diameter.
To confirm our computational prediction that hyperproliferation alone (that is, without mechanical changes) is insufficient to induce the formation of endophytic lesions (Extended Data Fig. 8c ), we used Fbw7 flox/flox ;Krt19 creERT (FCk19) mice, in which Fbw7 inactivation induces hyperproliferation of duct cells without leading to oncogenic transformation 2, 25 .
Fbw7
flox/flox duct cells had no alterations in pMLC2 intensity or integrin levels, as compared with wild-type cells ( Fig. 4a and Extended Data Fig. 8e-h ). FLASH imaging identified local duct-cell crowding and a mild expansion of the duct lumen without neoplastic deformations (Fig. 4b, c) . These findings support our model predictions that hyperproliferation alone cannot account for the diameter-dependent formation of exophytic versus endophytic lesions, and that only endophytic lesion growth requires altered apical-basal tension.
To determine whether cytoskeletal alterations could be used to distinguish between hyperproliferative benign and malignant ductal reactions, we compared cellular pMLC2 localization and Itga2 expression in caerulein-induced pancreatitis 26 , genetic hyperproliferation of FCk19 mice and early neoplastic lesions of KPC mice. Although pMLC2 was apically depleted in transformed duct cells, it was maintained in reactive and hyperproliferative ducts (Extended Data Fig. 9a-c) . Itga2 was strongly expressed in transformed lesions, but not in reactive or hyperproliferative ducts (Extended Data Fig. 9d ). Thus, cytoskeletal redistribution distinguishes oncogene-induced ductal transformation from benign hyperproliferation.
To test our hypothesis that ductal deformation is dependent on duct diameter, we developed a continuum theory of a circular epithelium subjected to asymmetric apical-basal surface tension [27] [28] [29] (Extended Data Fig. 10a and Supplementary Modelling Procedures). We considered the deformation induced by a localized patch of transformed epithelium. Reflecting the cytoskeletal changes in transformed cells, we assumed that the patch had increased basal and decreased apical tension, which leads to a preferred inward curvature of the transformed tissue (Extended Data Fig. 10b) . In small tubes, this tension imbalance is not large enough to overcome the resistance of the surrounding epithelium and the lesion grows outwards in an exophytic manner (Extended Data Fig. 10c, left) . In large tubes, early tumours are more free to adopt their preferred invaginating shape, and the lesion grows inward (Extended Data Fig. 10c, right) . Our generic continuum model therefore predicts a transition from exophytic to endophytic lesion at a threshold tube radius that depends on the bending modulus of the tissue and the magnitude of the changes in apical-basal tension in the transformed region (Extended Data Fig. 10d ).
The simplicity of the continuum model suggested that the dependency of lesion shape on ductal diameter was a universal principle. Keratin 19 is a general marker of ductal epithelia 30 , and in KFCk19 mice-in addition to pancreatic cancer-we observed neoplastic lesions that resembled squamous cell carcinoma precursors in the airways of the lung, and biliary neoplasia in the intrahepatic biliary tree. In both organs, transformed cells showed apical-basal redistribution of pMLC2, which indicates that oncogenic Kras-driven cytoskeletal disruption is tissue-independent (Extended Data Fig. 10e, f) . The hepatic ductal system comprised both small and large ducts, which gave rise to exophytic and endophytic lesions, respectively. However, the bronchiolar tree of the lung is built only of airways with diameters Letter reSeArCH above 30 μm, which gave rise to endophytic neoplasia only (Fig. 4d-f) . Thus, a tube diameter of about 20 μm appears to be the threshold for the transition from exophytic to endophytic tumours during lesion initiation in different organs and cancers (Fig. 4g) . Together, our findings indicate that the local curvature of the source epitheliumcombined with mechanical changes within the transformed cellsinstructs the direction of epithelial deformation and ultimately directs tumour morphology.
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MEthodS
No statistical methods were used to predetermine sample size. Unless indicated otherwise, the experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. creERT mice received 2 injections. Mice were analysed 7 days, 10 days or 3 weeks after the last tamoxifen injection before macroscopic tumours were apparent. Ela1 creERT2 and Ptf1a creERT mice received 5 tamoxifen injections. To induce acute pancreatitis, mice were subjected to a short caerulein treatment. Mice received intraperitoneal injections of caerulein (Sigma-Aldrich) in PBS at a dose of 50 μg/kg bodyweight (7 times a day, at hourly intervals, for 2 days). Ela1 creERT2 and Ptf1a creERT mice were analysed after 2 to 5 months to study transformation. Wild-type mice were analysed 4 days after caerulein treatment to assess acute pancreatitis. In-situ retrograde pancreas ductal perfusion. Mice were euthanized by cervical dislocation, and under a stereo microscope the abdominal wall and peritoneum were opened and the pancreatic head located. A suture was placed around the first bifurcation of the extrahepatic biliary tree. With an insulin gauge, 50 μl of 12 mg/ml FITC-conjugated dextran (Sigma-Aldrich; average molecular mass 2,000,000) was injected into the hepato-pancreatic duct by cannulation of the duct through the duodenal papilla. FLASH. FLASH was developed for the rapid detection of a multitude of antigens in intact adult organs by mild non-destructive epitope recovery. Mice were euthanized by cervical dislocation. Cardiac perfusion was carried out with 20 ml PBS. Pancreata were removed attached to spleen and duodenum without perturbing the gland. Samples were fixed in 4% PFA overnight at 4 °C. Specimens were washed in PBT (0.4% Triton X-100 (Sigma-Aldrich) in PBS) twice for one hour and incubated in 200 mM boric acid (Sigma-Aldrich) with 4% SDS (Sigma-Aldrich) pH 7.0 overnight at 54 °C. Samples were washed in PBT for three hours with three volume exchanges. For immunolabelling, samples were incubated in FLASH blocking buffer (1% bovine serum albumin (Sigma-Aldrich), 5% DMSO (SigmaAldrich), 10% fetal calf serum (Gibco), 0.02% sodium azide (Sigma-Aldrich), 0.2% Triton X-100 in PBS) for one hour and incubated with antisera (all 1:100) for at least 16 h at room temperature on a nutator. Samples were washed by three volume exchanges PBS and incubated with secondary antibodies (all 1:100) for at least two days at room temperature. Samples were washed by three volume exchanges with PBS and gradually dehydrated in 30%, 50%, 75%, 2× 100% MetOH (SigmaAldrich), 1 hour each and-in a glass dish-immersed in methyl salicylate diluted in MetOH: 25%, 50%, 75%, 2× 100% methyl salicylate (Sigma-Aldrich), 30 min each, protected from light. Fluorescent proteins were stained by immunofluorescence. The following antibodies were used: amylase (goat, SCBT), GFP (goat, Abcam), GFP (mouse, Roche), Krt19 TROMA III (rat, DSHB), Tomato (rabbit, Rockland). All secondary antibodies were Alexa-dye conjugates (ThermoFisher). Nuclei were stained with DRAQ5 (Biostatus). Three-dimensional imaging. Organs were imaged on a Zeiss LSM 780 confocal microscope equipped with a 405-nm laser, an argon laser, a DPSS 561-nm laser, a HeNe 594-nm laser and a HeNe 633-nm laser using the following objective lenses: 10×/0.45 Ph2 Plan-Apochromat and 25×/0.8 LD LCI Plan-Apochromat. Because the limited working distance of the objectives did not permit imaging throughout the total thickness of the liver, liver lobes were bisected before imaging. Threedimensional image analysis and quantifications were performed using Imaris software (Bitplane). For display purposes, 3D images were gamma-corrected and clipping planes were used to crop datasets to the relevant areas. Scale bars refer to the centre of the 3D view. Three-dimensional quantifications of ductal and cellular geometry. Cell height, length and duct diameter were measured using Imaris software. Staining for Krt19 was used to demark the duct cell shape, and length and height were measured for individual cells using the measurement tool in optical sections. Five cells were measured per duct. The cell width was calculated using the quantifications of duct diameter and number of circumscribing cells. The duct diameter was measured in optical sections as the distance of opposing duct walls in one optical section (x-y plane) and perpendicular to it (z), and for each duct the average of both values was calculated. The number of duct-circumscribing cells was counted manually using 3D representation and optical sections.
Quantification of the relative division plane. Rosa26
Confetti ;Hnf1b creERT2 mice received 2 intraperitoneal tamoxifen injections at a dose of 100 mg/kg bodyweight, which induced recombination and fluorescent protein expression in less than 1% of duct cells as estimated from 3D imaging data. Clones were identified as clusters of directly adjacent cells that had the same fluorescence and subcellular fluorescent protein localization, and were surrounded by non-recombined cells. Using Imaris software, a surface describing the clone was automatically reconstructed in the channel of the fluorescent protein and split manually into surfaces describing each cell. Measurement points were positioned automatically into the centre of each surface (clone cell) and into the centre of the ductal lumen on both sides of the clone. The direction of cell division was determined automatically as the angle between the line connecting the cell surface centres and the line connecting the two measurement points in the ductal centre. Histopathology, immunohistochemistry and immunofluorescence. Histological and immunohistochemical analyses were performed as previously described 2 . The following antibodies were used: Cdh1 (rat, Novex), cortactin (rabbit, Abcam), GFP (goat, Abcam), GFP (mouse, Roche), ItgA2 (rabbit, Abcam), ItgA6 (rabbit, Abcam), ItgB1 (rabbit, Abcam), Ki67 (rat, Biolegend), Krt19 TROMA-III (rat, DSHB), MLC2 pSer19 (rabbit, NEB), myosin (rabbit, Abcam), nestin (mouse, BD transduction), Pdgfrβ (rabbit, NEB), PTK2 pTyr397 (rabbit, ThermoFisher), SMA (mouse, Agilent), SMA (mouse, Sigma), Tomato (rabbit, Rockland), Tomato (goat, Biorbyt), vimentin (rabbit, NEB), vinculin (mouse, Sigma-Aldrich). DBA-rhodamine and DBA-FITC were from Vectorlabs. F-actin was stained with phalloidin-TRITC (Sigma-Aldrich) and nuclei with DAPI (Sigma-Aldrich). F-actin staining of LSL KrasG12D ;p53 flox/flox ;Pdx1 cre pancreata and pancreata from wild-type littermate controls was performed on cryosections. Samples were embedded fresh in OCT medium and, after sectioning, fixed in 5% NBF for 10 min. Slides were washed in 0.2% Triton X-100 in PBS for 10 min and incubated in FLASH blocking buffer for 30 min. Staining reagent incubations were performed as above. Fluorescent stainings were imaged on a Zeiss LSM 780 confocal microscope. Chromogenic DAB stainings were imaged on a Zeiss Axio Scan Z1 Slide Scanner.
Quantification of staining intensities of actomyosin cortex components.
Immunofluorescence was performed as detailed above and imaged by confocal microscopy with a 40×/1.3 Plan-Apochromat oil immersion lens and two-tofourfold optical zoom, or with a 63×/1.46 Alpha Plan-Apochromat oil immersion objective. Lesions were classified as endophytic or exophytic on the basis of recombination status and morphological presentation. At early stages (10 days after recombination), some recombined non-transformed cells may have been included in the transformed classification, but at later stages transformed and non-transformed cells could be classified unambiguously. Per lesion, one optical section was analysed by intensity quantification of transformed cells and neighbouring wild-type cells using ImageJ software (NIH). Images were converted into composite images in which green and red marked Cdh1 (E-cadherin, to identify lateral membrane) and GFP (to identify genetically recombined cells), respectively, and the blue channel depicted the staining to be quantified. In each image, transformed cells were distinguished from wild type by GFP positivity and all cells with clear lateral Cdh1 staining were included in intensity measurements. Cells with apical or basal Cdh1 positivity were omitted from analysis as such a signal could be an artefact from the lateral surfaces of diagonally cut cells in front or behind the cell of interest. Thus, only cells cut through the middle were analysed. Basalapical intensity gradients were quantified for each cell. Pixel intensities of the blue channel along a straight line from the basal to the apical edge, equidistant from the two Cdh1-stained lateral cell edges, were recorded. To control for differences in cell height and overall staining intensity, the profiles were aligned for cell height by equally distributing values along the profile of the tallest cell without filling the resulting gaps, and normalized for intensity by subtracting the minimum value from each intensity profile and dividing by its average value. For comparison, normalization to nuclear levels was carried out and the localization of intensity peaks was similar in both methods.
For integrin quantifications, intensities were measured along the basal edges of transformed and neighbouring wild-type cells. Freehand lines were drawn between the Cdh1-stained lateral surfaces without crossing the Cdh1 signal to avoid carry-over from the lateral cortex. For each measured cell an additional intensity measurement was taken from the inner nuclear region. To account for overall differences in staining intensities between images, the nuclear intensity was used as background value for normalization per cell.
Human samples. Human pancreatic tissue sections were obtained from patients at King's College Hospital (n = 4) who were undergoing surgery for pancreatic neoplasia, who kindly consented to donating their samples for research. Sections were stained with H &E, or antibodies for SMA or PDGFRβ, and histopathologically examined. The collection of samples was approved by the NHS Health Research Authority following assessment by a Research Ethics Committee (HSC REC B; reference 16/NI/0119). Organoid culture. Pancreata were dissected and placed into ice-cold advanced DMEM/F-12 with 50 U/ml penicillin-streptomycin (Thermo Fisher). Tissue was minced on ice and incubated in 1 mg/ml collagenase V (Sigma-Aldrich) in DMEM/F-12 for 40 min at 37 °C. Digestion was stopped by addition of icecold advanced DMEM/F-12 and cells collected by centrifugation (300g, 5 min at 4 °C). Samples were further digested with trypsin for 5 min at room temperature and the reaction was stopped with ice-cold 2% FCS in PBS. The suspension was filtered through a 70-μm nylon mesh, and after centrifugation cells were plated in Matrigel. Organoid medium was used as previously described 42, 43 . Organoids were passaged once a week 1:10 using non-enzymatic TrypLE (Thermo Fisher). For pharmacological inhibition of MEK or ROCK activity, KPC organoids were incubated with 8 μM U0126 (Promega) in DMSO or 5 μM H1152 (Tocris) in DMSO or, as control, with an equivalent volume of DMSO in organoid medium for 16 h. For phosphatase inhibition, wild-type organoids were incubated with 2 μM okadaic acid (Tocris) in DMSO or 5 μM tautomycetin (Tocris) in DMSO or equivalent volume of DMSO (control) in organoid medium for 1 h. Experiments were carried out in triplicate for six independent organoid lines established from three wild-type mice and three LSL KrasG12D ;p53 flox/flox ;Pdx1 cre mice as indicated in the figure legends. Experiments were performed triple-blinded with one operator preparing the cells, a second operator adding drugs and a third operator staining and quantifying pMLC2 distribution. Organoid staining. For staining, organoids were cultured in 8-well glass-bottom dishes (Ibidi). Organoids were washed in PBS for 5 min and fixed in 5% NBF in 0.1% Triton X-100 in PBS for 15 min at room temperature. Cells were washed with 0.2% Triton X-100 in PBS for 30 min and incubated in FLASH blocking buffer for 1 h. Primary and secondary antibody incubations were extended overnight at 4 °C with 1 h washes in PBS after each incubation. For imaging, wells were immersed in fluorescence mounting medium (Dako). Images were taken on a Zeiss LSM 780 confocal microscope as described in 'Three-dimensional imaging' . Statistics. For experimental data, statistical significance was calculated using the Mann-Whitney Test (two-tailed, non-parametric, for unpaired samples) with P values as indicated in the figure legend.
Code availability. Custom code for the 3D vertex model is available upon request from S.A. (silvanusalt@gmail.com). Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data and protocols are included within the paper, Extended Data and Supplementary Information. Source Data for Figs. 1d, f, 2i-k, m, 3d, 4a, b, d and Extended Data Figs. 1d, f, 2b, 5e, 6b-g, i-l, 7d, f, i, j, m, n, 8a-d, f, h, 10e , f are provided with this paper. The original datasets and resulting analyses, as well as methodological details, are available from the corresponding authors upon reasonable request. For three Krt19-stained pancreata, z-stacks of at least 30 random high-magnification views were taken. Per view, the largest duct was identified and diameters were measured for four subsequent branching ducts to categorize the mode of arborization. For ducts with more than one furcation, the sequence was continued with the biggest duct ramifying from it. Terminal duct cells were assigned a duct diameter of 0 μm to indicate ending of the ductal tree. e, Cell division direction was measured on two-cell clones from tamoxifen-treated Rosa26 LSL-Confetti ;Hnf1b creERT2 mice as the angle determined with respect to the line connecting both nuclei and the directionality of the duct (n = 263 clones, 5 mice). f, Direction of cell division and cell aspect ratio in ducts of varying diameter. Solid lines represent exponential fits. Cell division, n = 263 clones, 5 mice; aspect ratio, n = 120 ducts, 7 mice. shown in Fig. 2h . Single-cell profiles were normalized to cellular average and aligned in length. * * * * P < 0.0001 (two-sided Mann-Whitney test). e, pMLC2 distribution in KC mice. Immunostaining for pMLC2 and Cdh1. Scale bar, 10 μm. Representative of two mice. f, Basal-apical pMLC2 intensity profile of KC cells (e), measured as shown in Fig. 2h . Single-cell profiles were normalized to cellular average and aligned in length. Data are mean ± s.e.m. of 219 cells. g-j, pMLC2 distribution in KPC organoids after MEK inhibition. g, h, Immunostaining for pMLC2 and Cdh1. Scale bars, 20 μm. Representative of three experiments with three KPC organoid lines. g, DMSO control. h, 8 μM U0126 treatment. i, Basal-apical pMLC2 intensity profiles of DMSO or U0126-treated organoids, measured as shown in Fig. 2h . Single-cell profiles were normalized to cellular average and aligned in length. Data are mean ± s.e.m. (DMSO, 105 cells; U0126, 133 cells). j, Ratio of apical to basal pMLC2 intensity of KPC organoids after DMSO or U0126 treatment. DMSO, 105 cells; U0126, 133 cells. Data are mean ± s.d.
* * * * P < 0.0001 (two-sided Mann-Whitney test). k, l, Immunostaining for pMLC2 and Cdh1. Scale bars, 20 μm. k, DMSO control. l, 5 μM ROCK inhibitor (H1152) treatment. Representative of two experiments with three KPC organoid lines. m, Basal-apical pMLC2 intensity profiles of DMSO-or H1152-treated organoids, measured as shown in Fig. 2h . Single-cell profiles were normalized to cellular average and aligned in length. Data are mean ± s.e.m. (DMSO, 59 cells; H1152,  38 cells) . n, Ratio of apical to basal pMLC2 intensity of KPC organoids after DMSO or H1152 treatment. DMSO, 60 cells; H1152, 37 cells. Data are mean ± s.d. NS, not significant, P = 0.5517 (two-sided Mann-Whitney test).
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